Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherri Dudal

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Clinical Immunology (Orlando, Fla.)|February 22, 2005
Cellular bioterrorism: how Brucella corrupts macrophage physiology to promote invasion and proliferationMaria-Pilar Jimenez de Bagues, Jimenez de Bagues Maria-Pilar, Sherri Dudal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
Release of LL-37 by activated human Vgamma9Vdelta2 T cells: a microbicidal weapon against Brucella suisSherri Dudal, Chrystell Turriere, Stephanie Bessoles, et al.
Bioanalysis|December 23, 2014
Use of generic LC-MS/MS assays to characterize atypical PK profile of a biotherapeutic monoclonal antibodyWai Siang Law, Jean-Christophe Genin, Christian Miess, et al.
The AAPS Journal|December 18, 2013
Assay formats: Recommendation for best practices and harmonization from the global bioanalysis consortium harmonization teamSherri Dudal, Daniel Baltrukonis, Rebecca Crisino, et al.
Bioanalysis|June 25, 2014
How the bioanalytical scientist plays a key role in interdisciplinary project teams in the development of biotherapeutics - a reflection of the European Bioanalysis ForumSherri Dudal, Roland F Staack, Daniela Stoellner, et al.
The AAPS Journal|April 30, 2015
Workshop Report: AAPS Workshop on Method Development, Validation, and Troubleshooting of Ligand-Binding Assays in the Regulated EnvironmentMarian Kelley, Lauren Stevenson, Michaela Golob, et al.
Mabs|April 26, 2017
Toward in vitro-to-in vivo translation of monoclonal antibody pharmacokinetics: Application of a neonatal Fc receptor-mediated transcytosis assay to understand the interplaying clearance mechanismsClaudia A Castro Jaramillo, Sara Belli, Anne-Christine Cascais, et al.
Neuron|September 5, 2025
The "five-star matrix" for patient-centric drug discovery and development in neuroscienceAxel Pähler, Eoin C O'Connor, Hayley Binch, et al.
Toxicologic Pathology|February 3, 2021
Review of the Technical, Toxicological, and PKPD Considerations for Conducting Inhalation Toxicity Studies on Biologic Pharmaceuticals-The Outcome of a Cross-Industry Working Group SurveyAlison Wolfreys, Jo Kilgour, Andrew D Allen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 13, 2016
Application of a MABEL Approach for a T-Cell-Bispecific Monoclonal Antibody: CEA TCBSherri Dudal, Heather Hinton, Anna M Giusti, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical Immunology (Orlando, Fla.)|February 22, 2005
Cellular bioterrorism: how Brucella corrupts macrophage physiology to promote invasion and proliferationMaria-Pilar Jimenez de Bagues, Jimenez de Bagues Maria-Pilar, Sherri Dudal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
Release of LL-37 by activated human Vgamma9Vdelta2 T cells: a microbicidal weapon against Brucella suisSherri Dudal, Chrystell Turriere, Stephanie Bessoles, et al.
Bioanalysis|December 23, 2014
Use of generic LC-MS/MS assays to characterize atypical PK profile of a biotherapeutic monoclonal antibodyWai Siang Law, Jean-Christophe Genin, Christian Miess, et al.
The AAPS Journal|December 18, 2013
Assay formats: Recommendation for best practices and harmonization from the global bioanalysis consortium harmonization teamSherri Dudal, Daniel Baltrukonis, Rebecca Crisino, et al.
Bioanalysis|June 25, 2014
How the bioanalytical scientist plays a key role in interdisciplinary project teams in the development of biotherapeutics - a reflection of the European Bioanalysis ForumSherri Dudal, Roland F Staack, Daniela Stoellner, et al.
The AAPS Journal|April 30, 2015
Workshop Report: AAPS Workshop on Method Development, Validation, and Troubleshooting of Ligand-Binding Assays in the Regulated EnvironmentMarian Kelley, Lauren Stevenson, Michaela Golob, et al.
Mabs|April 26, 2017
Toward in vitro-to-in vivo translation of monoclonal antibody pharmacokinetics: Application of a neonatal Fc receptor-mediated transcytosis assay to understand the interplaying clearance mechanismsClaudia A Castro Jaramillo, Sara Belli, Anne-Christine Cascais, et al.
Neuron|September 5, 2025
The "five-star matrix" for patient-centric drug discovery and development in neuroscienceAxel Pähler, Eoin C O'Connor, Hayley Binch, et al.
Toxicologic Pathology|February 3, 2021
Review of the Technical, Toxicological, and PKPD Considerations for Conducting Inhalation Toxicity Studies on Biologic Pharmaceuticals-The Outcome of a Cross-Industry Working Group SurveyAlison Wolfreys, Jo Kilgour, Andrew D Allen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 13, 2016
Application of a MABEL Approach for a T-Cell-Bispecific Monoclonal Antibody: CEA TCBSherri Dudal, Heather Hinton, Anna M Giusti, et al.
Pageof 3